Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers

Brain Communications(2024)10.1093/braincomms/fcae277Source: DataRank Database

Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers is a research paper published in Brain Communications (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.74)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Michela Marcatti ORCID,Nemil Bhatt ORCID,Rakez Kayed ORCID,Giulio Taglialatela ORCID,Pietro Scaduto ORCID

Live enrichment

PubMed:39239152 PMC:PMC11375858 OpenAlex:https://openalex.org/W4401646649

National Institute on Aging

Grant: R01-AG060718-01A1

National Institute on Aging

Grant: R01-AG073133-03

NIA NIH HHS

Grant: R01 AG073133

National Institutes of Health

Grant: 1R01AG060718-01A1

Calcineurin Mediates the Synergistic Toxicity of Tau and A? Oligomers

National Institutes of Health

Grant: 5R01AG073133-03

Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders

National Institutes of Health

FWCI

1.74

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae277/58833155/fcae277.pdf

publisherhttps://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae277/58833155/fcae277.pdf

publisherhttps://academic.oup.com/braincomms/article-pdf/6/5/fcae277/59865553/fcae277.pdf

journalhttps://doi.org/10.1093/braincomms/fcae277

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39239152

Fields of Study

Neuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

CalcineurinSynaptic plasticityNeurosciencePlasticityChemistryPsychologyMedicineInternal medicineMaterials scienceBiochemistryFK506LTPTauAlzheimer’s diseaseTacrolimusOriginal Article

Sustainable Development Goals

SDG 0: Good health and well-being